லாடம் க்ளேண்மர்க் மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from லாடம் க்ளேண்மர்க் மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In லாடம் க்ளேண்மர்க் மருந்துகள் Today - Breaking & Trending Today

Glenmark's Ryaltris® nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age


Glenmark s Ryaltris® nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age
News provided by
Share this article
Share this article
The launch will ensure much-needed access to a novel fixed-dose combination nasal spray for this chronic condition
This marks Glenmark s first innovative product approval in the European Union
MUMBAI, India, April 26, 2021 /PRNewswire/  Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, is concluding the final, national phase of its marketing approval application process to enable launch of its innovative nasal spray in 17 countries in the European Union. Ryaltris ....

United Kingdom , Czech Republic , South Korea , South Africa , L Vivs Ka Oblast , Saudi Arabia , Sachin Gupta , Seqirus Pty , Menarini Group , European Union , Latam Glenmark Pharmaceuticals , Glenmark Pharmaceuticals , Hikma Pharmaceuticals , China Co , Bausch Health , Glenmark Pharmaceuticals Limited , Executive Vice President , Business Head , Middle East , Grand Pharmaceutical , Glenmark Pharmaceuticals Ltd , Health Care Amp Hospitals , Medical Pharmaceuticals , Clinical Trials Amp Medical Discoveries , ஒன்றுபட்டது கிஂக்டம் , செக் குடியரசு ,

Glenmark Pharma gains after Ryaltris gets approval in Europe


Glenmark Pharmaceuticals rose 1.11% to Rs 565.25 after the company s Ryaltris nasal spray received an approval in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age.
The company is concluding the final, national phase of its marketing approval application process to enable launch of its innovative nasal spray in 17 countries in the European Union.
Ryaltris (olopatadine hydrochloride 665 mcg and mometasone furoate 25 mcg), will shortly be available in Austria, Belgium, Czech Republic, Germany, Denmark, Spain, Finland, France, Ireland, Italy, The Netherlands, Norway, Poland, Romania, Slovakia, Sweden, and the UK.
Glenmark will commercialise Ryaltris on its own in select markets. In some countries such as France, Italy, Spain and the Balkan region, Menarini Group will lead the commercialisation effort, as part of an exclusive licensing agreement signed with Glenmark in 2020. ....

United Kingdom , Czech Republic , South Africa , L Vivs Ka Oblast , Saudi Arabia , South Korea , Sachin Gupta , Menarini Group , European Union , Latam Glenmark Pharmaceuticals , Glenmark Pharmaceuticals , Hikma Pharmaceuticals , China Co , Bausch Health , Grand Pharmaceutical , Middle East , Capital Market , ஒன்றுபட்டது கிஂக்டம் , செக் குடியரசு , சவுதி அரேபியா , தெற்கு கொரியா , ஆச்சின் குப்தா , ஐரோப்பிய தொழிற்சங்கம் , லாடம் க்ளேண்மர்க் மருந்துகள் , க்ளேண்மர்க் மருந்துகள் , ஹிக்மா மருந்துகள் ,

Glenmark Pharma to launch its nasal spray Ryaltris in EU


Glenmark Pharma to launch its nasal spray Ryaltris in EU
Glenmark Pharma to launch its nasal spray Ryaltris in EU
NEW DELHI, Apr 26:Glenmark Pharma on Monday said it is concluding the final, national phase of its marketing approval application process to launch its nasal spray Ryaltris in 17 countries in the European Union (EU).
Glenmark said Ryaltris is now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age.
Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age. The drug relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and watery eyes. ....

United Kingdom , Czech Republic , Sachin Gupta , Glenmark Pharma , Menarini Group , European Union , Latam Glenmark Pharmaceuticals , Hikma Pharmaceuticals , Bausch Health , Executive Vice President , Business Head , Middle East , Glenmark Pharmaceuticals , ஒன்றுபட்டது கிஂக்டம் , செக் குடியரசு , ஆச்சின் குப்தா , க்ளேண்மர்க் பார்மா , ஐரோப்பிய தொழிற்சங்கம் , லாடம் க்ளேண்மர்க் மருந்துகள் , ஹிக்மா மருந்துகள் , பாஷ் ஆரோக்கியம் , நிர்வாகி துணை ப்ரெஸிடெஂட் , வணிக தலை , நடுத்தர கிழக்கு , க்ளேண்மர்க் மருந்துகள் ,